We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+10.69%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.63B
AUM Growth
+$354M
Cap. Flow
+$42.2M
Cap. Flow %
0.91%
Top 10 Hldgs %
6.93%
Holding
1,360
New
97
Increased
499
Reduced
329
Closed
106

Top Buys

Rank Stock Value
1
PHIN icon
Phinia Inc
PHIN
+$19.2M
2
TGNA
TEGNA Inc
TGNA
+$16.8M
3
KSS icon
Kohl's
KSS
+$15M
4
CENTA icon
Central Garden & Pet Co Class A
CENTA
+$14.5M
5
ADNT icon
Adient
ADNT
+$12.1M

Sector Composition

Rank Sector Weight
1 Financials 27.28%
2 Consumer Discretionary 14%
3 Industrials 12.72%
4 Technology 9.9%
5 Healthcare 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSVT
801
DELISTED
2seventy bio
TSVT
$645K 0.01%
136,700
+25,000
+22% +$113K
OMER icon
802
Omeros
OMER
$959M
$640K 0.01%
161,300
BIIB icon
803
Biogen
BIIB
$30.7B
$640K 0.01%
3,300
+1,300
+65% +$272K
SCPH
804
DELISTED
scPharmaceuticals
SCPH
$638K 0.01%
139,900
-49,100
-26% -$237K
ETSY icon
805
Etsy
ETSY
$7.85B
$633K 0.01%
11,400
+5,700
+100% +$323K
SCYX icon
806
SCYNEXIS
SCYX
$52M
$630K 0.01%
52,856
+6,262
+13% +$88.5K
CCLD icon
807
CareCloud
CCLD
$112M
$628K 0.01%
237,804
-29,790
-11% -$71.2K
INFU icon
808
InfuSystem Holdings
INFU
$249M
$620K 0.01%
92,600
+45,000
+95% +$292K
INOD icon
809
Innodata
INOD
$2.04B
$620K 0.01%
36,955
-4,400
-11% -$74.1K
TRVI icon
810
Trevi Therapeutics
TRVI
$2.64B
$620K 0.01%
185,481
BGSF icon
811
BGSF Inc
BGSF
$60M
$618K 0.01%
73,400
+32,800
+81% +$265K
TECX
812
Tectonic Therapeutic
TECX
$606M
$618K 0.01%
20,381
+600
+3% +$11K
AMGN icon
813
Amgen
AMGN
$222B
$612K 0.01%
1,900
-4,400
-70% -$1.44M
CATO icon
814
Cato Corp
CATO
$66.1M
$609K 0.01%
122,004
+2,278
+2% +$11.2K
MPTI icon
815
M-tron Industries
MPTI
$380M
$609K 0.01%
14,600
AFCG
816
AFC Gamma
AFCG
$63.4M
$609K 0.01%
59,600
-138,050
-70% -$1.33M
VRTX icon
817
Vertex Pharmaceuticals
VRTX
$126B
$605K 0.01%
1,300
RBKB icon
818
Rhinebeck Bancorp
RBKB
$194M
$604K 0.01%
65,314
-12,454
-16% -$103K
NCSM icon
819
NCS Multistage Holdings
NCSM
$125M
$603K 0.01%
30,182
+938
+3% +$17.7K
GAIA icon
820
Gaia
GAIA
$48.4M
$598K 0.01%
122,800
ACTG icon
821
Acacia Research
ACTG
$470M
$596K 0.01%
127,945
-109,251
-46% -$540K
HAPN
822
Happen Inc
HAPN
$2.24B
$589K 0.01%
51,557
-287,472
-85% -$3.07M
BMEA icon
823
Biomea Fusion
BMEA
$91.3M
$589K 0.01%
+58,300
New +$379K
ASRT
824
DELISTED
Assertio
ASRT
$588K 0.01%
33,240
+5,911
+22% +$117K
RLMD icon
825
Relmada Therapeutics
RLMD
$527M
$587K 0.01%
181,077

Similar funds

Bridgeway Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Bridgeway Capital Management held 1,360 positions worth $4.63B, up 8.3% from $4.27B the previous quarter. Its ten largest holdings account for 6.9% of the portfolio.

Bridgeway Capital Management's Q3 2024 filing shows 97 new, 499 increased, 329 reduced and 106 closed positions. Its largest new stake was Phinia Inc: 427,196 shares worth $19.7M. The largest sale was Abercrombie & Fitch, an estimated $11M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Bridgeway Capital Management's largest Q3 2024 buy was Phinia Inc: 427,196 shares worth $19.7M.
  • Bridgeway Capital Management added most to Central Garden & Pet Co Class A in Q3 2024, an estimated $14.5M increase.
  • Bridgeway Capital Management's biggest Q3 2024 reduction was Abercrombie & Fitch, cutting an estimated $11M.
  • Bridgeway Capital Management fully exited CleanSpark in Q3 2024, selling an estimated $7.03M.
  • Bridgeway Capital Management's ten largest holdings make up 6.9% of its $4.63B portfolio in Q3 2024.
  • Bridgeway Capital Management opened 97 new positions and closed 106 in Q3 2024.
  • Bridgeway Capital Management's portfolio value rose 8.3% quarter-over-quarter to $4.63B.

Based on Bridgeway Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.